English | Español

Regulatory
+ Regulatory
Press release submission | Jul 26, 2020

CRADLE GENOMICS: Expands Executive Team, Accelerating Efforts to Transform Non-Invasive Prenatal Testing and Patient Care
+ Regulatory
David Beasley | Jul 16, 2020

Patients should have more say on the value of treatments, scientists say
+ Regulatory
Press release submission | Jul 5, 2020

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

+ Regulatory
Press release submission | Jun 28, 2020

DAIICHI SANKYO: Provides Update on CHMP Review of Pexidartinib, a CSF1R Inhibitor for the Treatment of Patients with TGCT
+ Regulatory
David Beasley | Jun 26, 2020

Emergency room visits for strokes, heart attacks declined after COVID-19 crisis, study finds
+ Regulatory
Press release submission | Jun 21, 2020

REISTONE: Announces First Patient Dosed in a Phase II Global Study of SHR0302 JAK Inhibitor for Alopecia Areata
+ Regulatory
Press release submission | Jun 14, 2020

CANO HEALTH: Advises Patients Of Potential Data Security Issue
+ Regulatory
Bob Pepalis | Jun 3, 2020

Flawed data puts COVID-19 policies, treatments in doubt

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes